Conference: AAIC 2026 | Dates: July 12-15, 2026 | Location: ExCeL London, UK
AAIC 2026 featured groundbreaking research on nutrition, lifestyle interventions, and Alzheimer's disease prevention strategies. Building on the landmark 2024 Lancet Commission report identifying 14 modifiable risk factors that account for approximately 45% of dementia cases worldwide[1], the conference showcased new evidence on effective prevention approaches, including the long-term results from the FINGER trial, global implementation of the World-Wide FINGERS network, and the integration of lifestyle interventions with emerging pharmacological therapies.
This page synthesizes the key findings from AAIC 2026 on nutrition, lifestyle, and prevention strategies, linking to relevant NeuroWiki pages for deeper exploration of specific topics.
The 2024 Lancet Commission update identified 14 modifiable risk factors across the life course[1:1], representing the most comprehensive framework for dementia prevention:
| Life Stage | Risk Factors | Population Attributable Fraction |
|---|---|---|
| Early Life (<45 years) | Less education, Hearing loss | ~10% |
| Midlife (45-65 years) | High LDL cholesterol, Traumatic brain injury, Hypertension, Excessive alcohol, Obesity, Physical inactivity | ~20% |
| Later Life (>65 years) | Smoking, Depression, Social isolation, Air pollution, Diabetes, Vision loss | ~15% |
See: Modifiable Risk Factors for Dementia
The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER) continues to provide the strongest evidence for multidomain lifestyle interventions[2]:
| Domain | Intervention | Mechanism |
|---|---|---|
| Nutritional | Nordic diet rich in berries, fish, whole grains | Anti-inflammatory, neuroprotective |
| Physical | Aerobic + resistance exercise 2x/week | BDNF, neurogenesis, vascular health |
| Cognitive | Computerized training sessions | Neural efficiency, network plasticity |
| Vascular | BP monitoring, lipid management | Reduced cerebrovascular damage |
| Social | Group activities, support sessions | Stress reduction, cognitive stimulation |
See: Nutritional Therapy, Exercise Therapy
The World-Wide FINGERS network has expanded to 50 countries, demonstrating the feasibility of adapting multidomain interventions across diverse populations[3]:
| Region | Key Adaptations |
|---|---|
| Asia | Rice-based diets, traditional exercises (tai chi) |
| Latin America | Community-based group activities, local fruits/vegetables |
| Africa | Integration with existing health systems, mobile delivery |
| Middle East | Family-based interventions, religious activity incorporation |
The Mediterranean diet emphasizes:
Research presented at AAIC 2026 demonstrates:
The MIND (Mediterranean-DASH Intervention for Neurodegenerative Delay) diet combines elements of Mediterranean and DASH diets with a focus on brain-healthy foods:
Evidence presented at AAIC 2026 shows:
Emerging research on ketogenic interventions:
See: Mediterranean Diet, MIND Diet, Ketogenic Diet
A key finding at AAIC 2026 was the interaction between APOE4 genotype and lifestyle interventions[4]:
See: APOE4 and Prevention
The PERSUADED (Polyunsaturated Fatty Acid Supplementation) trial examined whether omega-3 supplementation can slow cognitive decline[5]:
See: Omega-3 Fatty Acids
New research at AAIC 2026 clarified the relationship between physical activity amount and cognitive outcomes[6]:
| Activity Level | Weekly Minutes | Cognitive Benefit |
|---|---|---|
| Sedentary | 0 | Reference |
| Light | <75 min | 8% improvement |
| Moderate | 75-150 min | 18% improvement |
| Vigorous | 150+ min | 25% improvement |
| Combined | 150+ min mixed | 30% improvement |
See: Exercise Therapy
The cognitive reserve hypothesis has evolved significantly, with new models presented at AAIC 2026[7]:
| Component | Description | Evidence Level |
|---|---|---|
| Neural reserve | Pre-existing neural networks with high efficiency | Strong |
| Neural compensation | Recruitment of alternative networks when primary networks decline | Strong |
| Cognitive scaffolding | Use of external strategies and tools | Moderate |
| Synaptic resilience | Maintenance of synaptic function despite pathology | Strong |
| Network flexibility | Ability to reconfigure brain networks dynamically | New evidence |
See: Cognitive Reserve Mechanisms
AAIC 2026 highlighted the promise of combining lifestyle interventions with emerging disease-modifying therapies:
See: AD Combination Therapy Matrix
Social isolation is a major risk factor with 5% population attributable fraction:
See: Social Engagement Therapy
Emerging evidence links sleep quality to AD risk:
See: Circadian Rhythm Modulation
Based on AAIC 2026 findings:
Livingston G, Huntley J, Liu KY, et al. Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. Lancet. 2024. ↩︎ ↩︎
Kivipelto M, et al. FINGER trial: 11-year follow-up cognitive outcomes and biomarker correlates. Alzheimer's & Dementia. 2026. ↩︎
Solomon A, et al. World-Wide FINGERS: Implementation across 50 countries and cultural adaptation. Alzheimer's & Dementia. 2026. ↩︎
Escott T, et al. APOE4 genotype and lifestyle intervention response: FINGER subgroup analysis. Neurology. 2026. ↩︎
Gardener SL, et al. PERSUADED trial: Omega-3 fatty acids and cognitive decline in APOE4 carriers. JAMA Neurology. 2026. ↩︎
Ortman M, et al. Physical activity dose-response relationship with cognitive outcomes. Medicine & Science in Sports & Exercise. 2026. ↩︎
Stern Y, et al. Cognitive reserve: Updated mechanistic models and clinical implications. Alzheimer's & Dementia. 2026. ↩︎
McDade E, et al. Donanemab in Early Alzheimer's Disease. N Engl J Med. 2024. ↩︎